Neuropathology Skin Punch Biopsy (IENFD) Autonomic Denervation

Small Fiber Neuropathy (SFN): Diagnosis, Skin Biopsy & Autonomic Denervation

Small Fiber Neuropathy (SFN) provides the definitive biological proof of organic pathology in approximately 50% of ME/CFS, POTS, and Long COVID patients. This clinical guide covers intraepidermal nerve fiber density (IENFD) biopsy testing, autonomic fiber loss, and emerging immunotherapies (IVIG).

1. What is Small Fiber Neuropathy?

Peripheral nerves consist of large myelinated motor and sensory fibers, and small, thinly myelinated (A-delta) and unmyelinated (C) fibers. Standard Electromyography (EMG) and Nerve Conduction Studies (NCS) test only large fibers and are invariably normal in ME/CFS.

Small fibers comprise the vast majority of all peripheral nerves. They perform two critical tasks:

  1. Somatic Sensory Function: Transmitting pain, burning, tingling, and temperature sensation from the skin.
  2. Autonomic Function: Regulating vascular tone (vasoconstriction), sudomotor sweat production, enteric gut motility, and microvascular perfusion.

2. Diagnostic Gold Standard: 3-mm Skin Punch Biopsy

Because small fibers cannot be visualized with electrical conduction tests, the gold standard diagnostic method is a 3-millimeter punch biopsy taken 10 cm above the lateral malleolus of the ankle and at the upper proximal thigh (PMID: 24189335).

Using PGP 9.5 immunohistochemical staining, pathologists count the Intraepidermal Nerve Fiber Density (IENFD) per linear millimeter under confocal microscopy. A density below the 5th percentile for age and sex confirms axonal degeneration of small fibers.

3. Therapeutic Implications: IVIG & Autoimmunity

In research spearheaded by Dr. Anne Louise Oaklander at Harvard / Massachusetts General Hospital, a large subset of post-viral SFN cases was found to be autoantibody-mediated. Patients with biopsy-proven small fiber neuropathy and functional autoantibodies may qualify for Intravenous Immunoglobulin (IVIG) therapy, which neutralizes circulating pathogenic autoantibodies and has demonstrated small fiber axonal regeneration in clinical trials.

Peer-Reviewed References

  1. Oaklander AL, et al. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia or chronic fatigue. Pain. 2013;154(11):2310-2316. PMID: 23748113.
  2. Novak P, et al. Autonomic impairment in myalgic encephalomyelitis/chronic fatigue syndrome with and without postural tachycardia syndrome. J Neurol. 2020;267(8):2400-2408. PMID: 32248351.
  3. Shoenfeld Y, et al. Small fiber neuropathy in autoimmune dysautonomias: role of autoantibodies and IVIG. Autoimmun Rev. 2020;19(4):102494. PMID: 32068132.